Global Breast Cancer Diagnostics Market Trends: Regional Breakdowns and Strategic Insights
Discover trends, market shifts, and competitive outlooks for the breast cancer diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Is the Estimated Market Size of the Breast Cancer Diagnostics Market In 2029?
In recent years, the market size for breast cancer diagnostics has experienced substantial growth. There is an anticipation of growth from $4.68 billion in 2024 to $5.04 billion in 2025, following a compound annual growth rate (CAGR) of 7.9%. Factors such as awareness and screening campaigns, mammography screening, advancements in technology, genetic testing and a multidisciplinary approach have significantly contributed to the growth in the historical period.
Expectations are high for the breast cancer diagnostics market to experience significant expansion in the near future. The market value is projected to reach $6.91 billion in 2029, increasing at a compound annual growth rate (CAGR) of 8.2%. The predicted expansion during the forecast period can be linked to the development and rising popularity of personalized medicine, liquid biopsies, 3d mammography (tomosynthesis), artificial intelligence, and machine learning, as well as the growing use of telemedicine and remote consultations. The forecast period is also anticipated to witness trends such as advancements in imaging technologies, the rise of personalised medicine, wider usage of liquid biopsies, and the integration of artificial intelligence and machine learning.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Breast Cancer Diagnostics Market?
The rising occurrence of breast cancer necessitates an increase in diagnostic tools, thus escalating the demand for the breast cancer diagnostics market. Recognized as the most prevalent type of cancer, breast cancer affects about 2.1 million women annually and results in the highest number of cancer-related deaths in women. The primary aim of early detection is to escalate the number of cases diagnosed at the initial state, thereby fostering effective treatment strategies which could potentially reduce the mortality rate from breast cancer. As an illustration, the American Cancer Society, a US-based organization dedicated to eradicating cancer, reported in January 2022 that about 287,850 new invasive breast cancer cases and 51,400 cases of DCIS are expected to be diagnosed among women in the United States this year, with a predicted 43,250 deaths as a result of breast cancer. As such, the increasing rate of breast cancer diagnoses is anticipated to propel the growth of the breast cancer diagnostics market.
Which Key Market Segments Comprise the Breast Cancer Diagnostics Market and Drive Its Revenue Growth?
The breast cancer diagnostics market covered in this report is segmented –
1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types
2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types
4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies
5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers
Subsegments:
1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis
2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy
3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing
4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests
5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=3284&type=smp
Which Areas Are Leading Regions in the Breast Cancer Diagnostics Market Expansion Across the Globe?
North America was the largest region in the breast cancer diagnostics market in 2023. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Strategic Trends Steering the Breast Cancer Diagnostics Market Direction?
Progression in technology is a significant trend in the breast cancer diagnostics market. There have been developments in numerous new methods that can be applied in detecting and treating breast cancer. Breast tomosynthesis, also known as 3D mammography, creates images of the breast from multiple perspectives and converts them into a 3-D model. Niramai, an Indian health-tech firm, in September 2022, introduced an inventive solution named Thermalytix. This is an automated tool for breast cancer screening and diagnosis, merging thermal imaging and AI.
View the full report here:
https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report
How Is the Breast Cancer Diagnostics Market Conceptually Defined?
Breast cancer diagnostics refer to the various methods, tests, and procedures used to detect and diagnose breast cancer in individuals. These diagnostics help identify the presence of cancer cells in breast tissue, determine the stage of cancer, and guide treatment decisions.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3284
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model